The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.
PPTA works globally to:
PPTA Remembers Corey Dubin +
The Plasma Protein Therapeutics Association (PPTA) notes with sadness the passing of Corey Dubin, President Emeritus of the Committee of Ten Thousand and longtime advocate in the hemophilia community.Read More
Registration now open for the 2017 International Plasma Protein Congress! +
PPTA Chosen to Join Mission to China +
On Oct. 16-21, the Chairman of the PPTA Global Board of Directors and the PPTA President & CEO will be joining U.S. Department of Commerce-led Healthcare Business Development Mission to China.Read More